E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedReviewed
A Cross-National Comparison of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome at Tertiary Care Settings from the US and Spain.
Bhatia, Shaun, Olczyk, Nicole, Jason, Leonard A et al. · American journal of social sciences and humanities · 2020 · DOI
Quick Summary
This study compared ME/CFS patients in the United States and Spain to see if the disease affects people differently depending on where they live. Researchers found that Spanish patients reported worse overall health and more severe symptoms, particularly pain and hormone-related problems, compared to American patients. The differences may be due to how each country handles disability benefits, how doctors view ME/CFS, and how easily patients can see specialists.
Why It Matters
Understanding how ME/CFS manifests across different healthcare systems and cultures can help researchers identify whether observed differences are disease-related or influenced by social and medical factors. This knowledge may improve international clinical standards and highlight the importance of culturally-sensitive healthcare approaches for ME/CFS patients worldwide.
Observed Findings
- Spanish patients scored significantly lower than US patients on five SF-36 domains: physical functioning, bodily pain, general health, role emotional, and mental health
- Spanish patients reported more symptoms across all DePaul Symptom Questionnaire items
- Pain and neuroendocrine symptoms showed the largest differences between Spanish and US populations
- Both samples met the same Fukuda diagnostic criteria, yet reported different symptom severity and functional impairment
Inferred Conclusions
- Healthcare system differences, including disability policy frameworks and access to specialist care, may influence patient-reported symptom severity and functional outcomes
- Cultural and healthcare perception of ME/CFS may affect how patients experience and report their illness
- International comparisons of ME/CFS suggest the need for standardized, culturally-informed assessment approaches
Remaining Questions
- Are the observed differences due to actual variation in disease severity or to differences in how patients report symptoms across cultures?
- How do disability policies and healthcare system structures specifically impact ME/CFS outcomes and patient-reported symptoms?
- Would similar patterns emerge in primary care or community-based samples, or are findings specific to tertiary referral populations?
What This Study Does Not Prove
This study cannot determine whether differences between countries are caused by actual biological disease variation, healthcare system factors, or patient reporting differences. The cross-sectional design shows correlation only, not causation. Additionally, the study was limited to tertiary care settings, so findings may not represent the broader ME/CFS patient populations in either country.
Tags
Symptom:Cognitive DysfunctionPainFatigueSensory Sensitivity
Method Flag:PEM Not DefinedWeak Case DefinitionExploratory OnlyNo Controls
Metadata
- DOI
- 10.20448/801.51.104.115
- PMID
- 34109300
- Review status
- Editor reviewed
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.